CureVac (CVAC) Earnings Date & Reports

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CVAC is expected to report earnings to fall 116.23% to -24 cents per share on April 23

Q4'24

Est.

$-0.25

Q3'24

Beat

by $0.10

Q2'24

Missed

by $0.04

Q1'24

Est.

$-0.31

Q4'23

Missed

by $0.20

The last earnings report on November 12 showed earnings per share of $1.51, beating the estimate of $1.41. With 237.18K shares outstanding, the current market capitalization sits at 625.90M.

View a ticker or compare two or three

Compare

CVAC